Taisho Pharmaceutical Co., Ltd selected site
Fukuoka, Japan
NCT Number: NCT03413592
The purpose of this study is to verify the intra-individual difference of the SDLP values in driving simulator.
Looking for future studies?
Notify Me21 year–64 year
Male
Interventional
Not applicable
Fukuoka, Japan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Driving with simulator program for SDLP measurement
Driving with simulator program for DCV measurement
Driving with simulator program for BRT measurement
Time frame: 60 min
Time frame: 5 min
Time frame: 5 min
Taisho Pharmaceutical Co., Ltd.
Industry
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2: Verification of Intra-individual Difference
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05870072
Balance, Postural, Behavior
Kütahya, Centre, Turkey (Türkiye)
View Trial DetailsNCT07241065
Healthy Participants
Berlin, Germany
View Trial DetailsNCT07214766
Healthy Participants
Anaheim, California, United States
View Trial DetailsNCT07444424
Body Weight, Diabetes Mellitus
Fukuoka, Japan
View Trial Details